Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Lopes

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
Breast Cancer Research and Treatment|April 2, 2013
A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancerPui San Tan, Benjamin Haaland, Alberto J Montero, et al.
Oncotarget|October 15, 2017
Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysisYassine Ridouane, Gilberto Lopes, Geoffrey Ku, et al.
Current Oncology Reports|October 21, 2011
Bevacizumab in the treatment of metastatic breast cancer: friend or foe?Alberto J Montero, Mauricio Escobar, Gilberto Lopes, et al.
Cancers|April 13, 2023
Lung Cancer Incidence by Detailed Race-EthnicityHannah M Cranford, Tulay Koru-Sengul, Gilberto Lopes, et al.
Hematological Oncology|October 20, 2020
Clinical trial risk in leukemia: Biomarkers and trial designAlice J Li, Jasper P Dhanraj, Gilberto Lopes, et al.
Ecancermedicalscience|March 28, 2019
Implementation of diagnostic resources for cancer in developing countries: a focus on PET/CTHaydeé C Verduzco-Aguirre, Gilberto Lopes, Enrique Soto-Perez-De-Celis
European Journal of Cancer (Oxford, England : 1990)|September 15, 2015
Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: results by performance status, EGFR mutation, histology and response to previous inductionPui San Tan, Gilberto Lopes, Sanchalika Acharyya, et al.
The Lancet. Oncology|March 6, 2025
Revolutionising cancer treatment access in low-income and middle-income countries: a sustainable approachAmy Israel, Cary Adams, Gilberto Lopes, et al.
The Prostate|January 20, 2017
Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect ComparisonAkhil Chopra, Mina Georgieva, Gilberto Lopes, et al.
Radiology and Oncology|September 30, 2017
Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase InhibitorsMatjaz Zwitter, Antonio Rossi, Massimo Di Maio, et al.
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Breast Cancer Research and Treatment|April 2, 2013
A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancerPui San Tan, Benjamin Haaland, Alberto J Montero, et al.
Oncotarget|October 15, 2017
Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysisYassine Ridouane, Gilberto Lopes, Geoffrey Ku, et al.
Current Oncology Reports|October 21, 2011
Bevacizumab in the treatment of metastatic breast cancer: friend or foe?Alberto J Montero, Mauricio Escobar, Gilberto Lopes, et al.
Cancers|April 13, 2023
Lung Cancer Incidence by Detailed Race-EthnicityHannah M Cranford, Tulay Koru-Sengul, Gilberto Lopes, et al.
Hematological Oncology|October 20, 2020
Clinical trial risk in leukemia: Biomarkers and trial designAlice J Li, Jasper P Dhanraj, Gilberto Lopes, et al.
Ecancermedicalscience|March 28, 2019
Implementation of diagnostic resources for cancer in developing countries: a focus on PET/CTHaydeé C Verduzco-Aguirre, Gilberto Lopes, Enrique Soto-Perez-De-Celis
European Journal of Cancer (Oxford, England : 1990)|September 15, 2015
Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: results by performance status, EGFR mutation, histology and response to previous inductionPui San Tan, Gilberto Lopes, Sanchalika Acharyya, et al.
The Lancet. Oncology|March 6, 2025
Revolutionising cancer treatment access in low-income and middle-income countries: a sustainable approachAmy Israel, Cary Adams, Gilberto Lopes, et al.
The Prostate|January 20, 2017
Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect ComparisonAkhil Chopra, Mina Georgieva, Gilberto Lopes, et al.
Radiology and Oncology|September 30, 2017
Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase InhibitorsMatjaz Zwitter, Antonio Rossi, Massimo Di Maio, et al.
Pageof 18